The development of efficient strategies to deliver therapeutics to high-grade brain tumors is critically needed due to the poor clinical efficacy of currently available treatments. This proposal seeks to evaluate intranasal delivery of mesenchymal stem cells for brain tumor therapy.
|Effective start/end date||11/1/15 → 8/31/17|
- National Institute of Neurological Disorders and Stroke (7R21NS089802-03)
Cell- and Tissue-Based Therapy
Mesenchymal Stromal Cells